118 related articles for article (PubMed ID: 30287259)
1. An ELISA for quantifying GPIHBP1 autoantibodies and making a diagnosis of the GPIHBP1 autoantibody syndrome.
Miyashita K; Fukamachi I; Machida T; Nakajima K; Young SG; Murakami M; Beigneux AP; Nakajima K
Clin Chim Acta; 2018 Dec; 487():174-178. PubMed ID: 30287259
[TBL] [Abstract][Full Text] [Related]
2. GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia.
Hu X; Dallinga-Thie GM; Hovingh GK; Chang SY; Sandoval NP; Dang TLP; Fukamachi I; Miyashita K; Nakajima K; Murakami M; Fong LG; Ploug M; Young SG; Beigneux AP
J Clin Lipidol; 2017; 11(4):964-971. PubMed ID: 28666713
[TBL] [Abstract][Full Text] [Related]
3. Chylomicronemia from GPIHBP1 autoantibodies.
Miyashita K; Lutz J; Hudgins LC; Toib D; Ashraf AP; Song W; Murakami M; Nakajima K; Ploug M; Fong LG; Young SG; Beigneux AP
J Lipid Res; 2020 Nov; 61(11):1365-1376. PubMed ID: 32948662
[TBL] [Abstract][Full Text] [Related]
4. GPIHBP1 autoantibody syndrome during interferon β1a treatment.
Eguchi J; Miyashita K; Fukamachi I; Nakajima K; Murakami M; Kawahara Y; Yamashita T; Ohta Y; Abe K; Nakatsuka A; Mino M; Takase S; Okazaki H; Hegele RA; Ploug M; Hu X; Wada J; Young SG; Beigneux AP
J Clin Lipidol; 2019; 13(1):62-69. PubMed ID: 30514621
[TBL] [Abstract][Full Text] [Related]
5. An enzyme-linked immunosorbent assay for measuring GPIHBP1 levels in human plasma or serum.
Miyashita K; Fukamachi I; Nagao M; Ishida T; Kobayashi J; Machida T; Nakajima K; Murakami M; Ploug M; Beigneux AP; Young SG; Nakajima K
J Clin Lipidol; 2018; 12(1):203-210.e1. PubMed ID: 29246728
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.
Beigneux AP; Miyashita K; Ploug M; Blom DJ; Ai M; Linton MF; Khovidhunkit W; Dufour R; Garg A; McMahon MA; Pullinger CR; Sandoval NP; Hu X; Allan CM; Larsson M; Machida T; Murakami M; Reue K; Tontonoz P; Goldberg IJ; Moulin P; Charrière S; Fong LG; Nakajima K; Young SG
N Engl J Med; 2017 Apr; 376(17):1647-1658. PubMed ID: 28402248
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic testing and measurement of levels of GPIHBP1 autoantibodies in patients with severe hypertriglyceridemia: The importance of identifying the underlying cause of hypertriglyceridemia.
Strøm TB; Tveita AA; Bogsrud MP; Leren TP
J Clin Lipidol; 2024; 18(1):e80-e89. PubMed ID: 37981531
[TBL] [Abstract][Full Text] [Related]
8. GPIHBP1 autoantibody is an independent risk factor for the recurrence of hypertriglyceridemia-induced acute pancreatitis.
Zhang G; Yang Q; Mao W; Hu Y; Pu N; Deng H; Yu X; Zhang J; Zhou J; Ye B; Li G; Li B; Ke L; Tong Z; Murakami M; Kimura T; Nakajima K; Cao W; Liu Y; Li W
J Clin Lipidol; 2022; 16(5):626-634. PubMed ID: 36064883
[TBL] [Abstract][Full Text] [Related]
9. A case of hyperchylomicronemia associated with GPIHBP1 autoantibodies and fluctuating thyroid autoimmune disease.
Nozue T; Tada H; Murakami M; Michishita I
J Clin Lipidol; 2023; 17(1):68-72. PubMed ID: 36402671
[TBL] [Abstract][Full Text] [Related]
10. Intermittent chylomicronemia caused by intermittent GPIHBP1 autoantibodies.
Ashraf AP; Miyashita K; Nakajima K; Murakami M; Hegele RA; Ploug M; Fong LG; Young SG; Beigneux AP
J Clin Lipidol; 2020; 14(2):197-200. PubMed ID: 32107180
[TBL] [Abstract][Full Text] [Related]
11. The role of plasma lipoprotein lipase, hepatic lipase and GPIHBP1 in the metabolism of remnant lipoproteins and small dense LDL in patients with coronary artery disease.
Muraba Y; Koga T; Shimomura Y; Ito Y; Hirao Y; Kobayashi J; Kimura T; Nakajima K; Murakami M
Clin Chim Acta; 2018 Jan; 476():146-153. PubMed ID: 29174344
[TBL] [Abstract][Full Text] [Related]
12. The effect of combined diet and exercise intervention on body weight and the serum GPIHBP1 concentration in overweight/obese middle-aged women.
Aruga M; Tokita Y; Nakajima K; Kamachi K; Tanaka A
Clin Chim Acta; 2017 Dec; 475():109-115. PubMed ID: 29056530
[TBL] [Abstract][Full Text] [Related]
13. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65.
Chen S; Willis J; Maclean C; Ananieva-Jordanova R; Amoroso MA; Brooking H; Powell M; Collins A; Bennett S; Mitchell S; Burne P; Furmaniak J; Smith BR
Clin Chim Acta; 2005 Jul; 357(1):74-83. PubMed ID: 15963796
[TBL] [Abstract][Full Text] [Related]
14. Novel mutations in the GPIHBP1 gene identified in 2 patients with recurrent acute pancreatitis.
Ariza MJ; Martínez-Hernández PL; Ibarretxe D; Rabacchi C; Rioja J; Grande-Aragón C; Plana N; Tarugi P; Olivecrona G; Calandra S; Valdivielso P
J Clin Lipidol; 2016; 10(1):92-100.e1. PubMed ID: 26892125
[TBL] [Abstract][Full Text] [Related]
15. Quantification of lipoprotein lipase in mouse plasma with a sandwich enzyme-linked immunosorbent assay.
Kimura T; Miyashita K; Fukamachi I; Fukamachi K; Ogura K; Yokoyama E; Tsunekawa K; Nagasawa T; Ploug M; Yang Y; Song W; Young SG; Beigneux AP; Nakajima K; Murakami M
J Lipid Res; 2024 Apr; 65(4):100532. PubMed ID: 38608546
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies that bind to the Ly6 domain of GPIHBP1 abolish the binding of LPL.
Hu X; Sleeman MW; Miyashita K; Linton MF; Allan CM; He C; Larsson M; Tu Y; Sandoval NP; Jung RS; Mapar A; Machida T; Murakami M; Nakajima K; Ploug M; Fong LG; Young SG; Beigneux AP
J Lipid Res; 2017 Jan; 58(1):208-215. PubMed ID: 27875259
[TBL] [Abstract][Full Text] [Related]
17. GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding.
Beigneux AP; Fong LG; Bensadoun A; Davies BS; Oberer M; Gårdsvoll H; Ploug M; Young SG
Circ Res; 2015 Feb; 116(4):624-32. PubMed ID: 25387803
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to IA-2 in type 1 diabetes: measurements with a new enzyme-linked immunosorbent assay.
Kawasaki E; Yamaguchi H; Hattori H; Egashira T; Eguchi K
Ann N Y Acad Sci; 2002 Apr; 958():241-6. PubMed ID: 12021115
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cells respond to hyperglycemia by increasing the LPL transporter GPIHBP1.
Pei-Ling Chiu A; Wang F; Lal N; Wang Y; Zhang D; Hussein B; Wan A; Vlodavsky I; Rodrigues B
Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1274-83. PubMed ID: 24735886
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocyte VEGF Regulates Endothelial Cell GPIHBP1 to Relocate Lipoprotein Lipase to the Coronary Lumen During Diabetes Mellitus.
Chiu AP; Wan A; Lal N; Zhang D; Wang F; Vlodavsky I; Hussein B; Rodrigues B
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):145-55. PubMed ID: 26586663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
